Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 3/20 | 0.43 |
| ▸ | DRD3 | P35462 | 7/20 | 0.41 |
| ▸ | DRD2 | P14416 | 5/20 | 0.41 |
| ▸ | DRD4 | P21917 | 4/20 | 0.41 |
| ▸ | ADH1C | P00326 | 2/20 | 0.41 |
| ▸ | FYN | P06241 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18747695 | 0.88 | ADH1A (0.39) | ADH1ADRD3DRD2DRD4ADH1C | |
| SCHEMBL11458712 | 0.87 | DRD2 (0.41) | ADH1ADRD3DRD2DRD4ADH1C | |
| Ammonia Solution, Strong SCHEMBL28049353 | 0.86 | DRD2 (0.40) | ADH1ADRD3DRD2DRD4ADH1C | |
| SCHEMBL18251488 | 0.83 | SLC6A4 (0.41) | DRD3DRD2DRD4FYN | |
| SCHEMBL516269 | 0.81 | ADH1A (0.54) | ADH1ADRD3DRD2DRD4ADH1C | |
| SCHEMBL11073680 | 0.81 | ADH1A (0.54) | ADH1ADRD3DRD2DRD4ADH1C | |
| SCHEMBL22541111 | 0.81 | ADH1A (0.54) | ADH1ADRD3DRD2DRD4ADH1C | |
| SCHEMBL516016 | 0.79 | ADH1A (0.52) | ADH1ADRD3DRD2DRD4ADH1C | |
| SCHEMBL15865807 | 0.77 | DRD3 (0.48) | ADH1ADRD3DRD2DRD4ADH1C | |
| SCHEMBL13851756 | 0.77 | HRH4 (0.37) | ADH1AADH1CMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10509314-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-12-17 | — | — | US | disclosed |
| US-20170108774-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-04-20 | — | — | US | disclosed |
| US-20170108774-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10509314-B2 | Resist composition and patterning process | SRMS, SLC11A2, PCNA | ADH1A 3801/4885DRD3 2270/4885DRD2 1071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.